Hormone receptor and prematurity risk
A key hormone receptor evolved quickly as or early humans migrated from Africa, producing localized gene changes that may affect modern women’s risk of preterm birth, according to a Stanford-led study.
Karl Deisseroth wins Kyoto Prize
The award, which includes a gift of 100 million yen (about $913,000), recognizes the neuroscientist for pioneering and advancing a technology for studying brain circuits.
Biomarker for flu susceptibility discovered
Scientists at Stanford are believed to be the first to have discovered a biomarker that can predict who will be most susceptible to influenza.
Blood test predicts premature birth
Measuring RNA fragments in a pregnant woman’s blood gives a reliable estimate of the baby’s due date and can predict if the baby will arrive prematurely, a Stanford-led team has shown.
Cellular ‘death code’ discovered
Stanford scientists and their collaborators have discovered a molecule that initiates the final, crucial step in a type of cell death.
Study finds problems with prescriptions
New research indicates that 11 million Americans may need to talk to their doctor about taking different prescriptions of aspirin, statins and blood pressure medications, according to a study led by Stanford researchers.
Neurons quickly generated from blood
Fresh or frozen human blood samples can be directly transformed into patient-specific neurons to study disorders such as schizophrenia and autism, Stanford researchers find.
D-limonene could offset dry mouth in cancer patients
A Stanford collaboration between clinical and basic science researchers has led to the identification of a compound that could improve the quality of life for head and neck cancer patients.
Magazine explores listening, hearing
The spring issue of Stanford Medicine magazine focuses on the importance of listening and hearing, and how new discoveries could improve both.
PET tracer predicts success of cancer ‘vaccine’
With a radioactive tracer, scientists can use a PET scan to quickly tell whether a cancer immunotherapy will be effective or not, according to a new Stanford study.
Leading in Precision Health
Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise.
A Legacy of Innovation
Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.